Related Experiment Videos
Combined immunodeficiency with defective expression in major histocompatibility complex class II genes
1Department of Pediatrics, Hôpital des Enfants-Malades, Paris.
Clinical Immunology and Immunopathology
|November 1, 1991
Summary
MHC class II deficient Severe Combined Immunodeficiency (SCID) is a rare inherited disorder where immune cells cannot properly present antigens. This leads to severe immune dysfunction and is often fatal without a bone marrow transplant.
Area of Science:
- Immunology
- Genetics
- Cell Biology
Background:
- Inherited immunodeficiencies can present with normal lymphocyte differentiation but impaired function.
- MHC class II deficiency is a specific type of combined immunodeficiency characterized by absent MHC class II gene expression.
- This autosomal recessive disorder has a severe clinical course.
Purpose of the Study:
- To describe the clinical and immunological characteristics of MHC class II deficient SCID.
- To investigate the underlying mechanisms of immune dysfunction in this condition.
- To highlight the importance of MHC class II molecules in adaptive immunity.
Main Methods:
- Clinical case descriptions of affected patients.
- Immunological assays to assess T and B cell function (in vivo and in vitro responses to antigens and mitogens).
- Analysis of cell surface molecule expression (HLA class I and class II).
Main Results:
- Patients exhibited normal T and B lymphocyte differentiation but defective antigen-specific responses.
- Absence of all HLA class II molecules (DR, DQ, DP) on cell surfaces was observed, while HLA class I was present.
- In vitro reactivity to mitogens was normal, suggesting antigen presentation defect.
Conclusions:
- MHC class II deficiency results in severe combined immunodeficiency due to impaired antigen presentation.
- The absence of MHC class II molecules prevents effective T cell sensitization.
- A defect in the regulation of MHC class II gene expression is strongly suspected as the cause.